Mind over migraine: Disease burden, innovative therapies, and managed care trends in treating migraine disease [0.03%]
战胜偏头痛：偏头痛的疾病负担、创新疗法及医疗趋势
Bridget Flavin;AMCP
Bridget Flavin;AMCP
Migraine is a genetically influenced complex neurological disease characterized by attacks of moderate to severe headaches and a variety of concomitant symptoms. Migraine disease can significantly impact individuals' daily activities and qu...
Budget impact analysis of revumenib for the treatment of relapsed or refractory acute leukemias with a KMT2A translocation in the United States [0.03%]
美国瑞武门布治疗复发或难治性KMT2A易位急性白血病的预算影响分析
Ivo Abraham,Pam Martin,Shailja Vaghela et al.
Ivo Abraham et al.
Background: Acute leukemias (ALs), including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), are heterogeneous diseases characterized by different phenotypic, genetic, and molecular alterations that c...
Optimization of oncology biomarker testing in managed care: Best practices and consensus recommendations from an AMCP Market Insights program [0.03%]
肿瘤生物标志物检测的优化：AMCP市场洞察项目中的最佳实践和共识建议
Diana Brixner,Terry Richardson,Catherine M Lockhart et al.
Diana Brixner et al.
Precision medicine in oncology using actionable molecular biomarkers to guide treatment selection has been associated with favorable outcomes; however, many potentially eligible patients do not receive it. This Academy of Managed Care Pharm...
Reductions in medical visits and hospitalizations following berotralstat initiation in patients with hereditary angioedema in the United States [0.03%]
美国赫杰特奇病患者接受伯罗司他治疗后在美国的求医问诊和住院次数减少
Sandra C Christiansen,Lorena Lopez-Gonzalez,Sean D MacKnight et al.
Sandra C Christiansen et al.
Background: Hereditary angioedema (HAE) is a rare disease characterized by unpredictable recurrent, debilitating, and potentially fatal attacks of subcutaneous and submucosal tissue swelling. ...
Clinical evaluation of zavegepant for the acute treatment of migraine [0.03%]
扎沃 gepant 治疗急性偏头痛的临床评价
Huiqiao Fan,Janette Wadolowski,Ryan Shan et al.
Huiqiao Fan et al.
Zavegepant is the first intranasal calcitonin gene-related peptide receptor antagonist approved for the acute treatment of migraine and offers a new nonoral option for patients. This article reports the findings of a comprehensive literatur...
Impact of pharmacist-physician collaborative care on hemoglobin A1c and blood pressure quality measure achievement in primary care [0.03%]
药剂师-医生合作护理对初级保健中糖化血红蛋白和血压质量测量达标的影响
Tyler D Wagner,Dave L Dixon,Yongyun Shin et al.
Tyler D Wagner et al.
Background: Multidisciplinary primary care models incorporating pharmacists have emerged to improve glycemic control in patients with uncontrolled type 2 diabetes mellitus (T2DM). Healthcare Effectiveness Data and Informa...
Real-world familiarity with US biosimilar regulatory guidelines and interchangeability state laws among pharmacists and physicians treating immunological disorders [0.03%]
美国药师和医师对生物类似药监管指南及互换性州法律的现实认识度——针对免疫系统疾病患者的治疗团队的一份研究
You-Li Ling,Danielle Gentile,Angele Kotomale et al.
You-Li Ling et al.
Background: The US Food and Drug Administration (FDA) considers an interchangeable biosimilar to produce the same clinical result as the reference product in any given patient. Interchangeability standards indicate that t...
Examining the relationship between adherence and the number of cardiometabolic medications: Findings for patients with type 2 diabetes within a Tribal health care system [0.03%]
土著医疗体系中2型糖尿病患者用药依从性与心血管代谢药物数量之间关系的调查研究
Tarah Nelson,Chasity Pierre,Yingwei Yao et al.
Tarah Nelson et al.
Background: The literature is inconclusive regarding the association between adherence and the number of concurrent prescribed medications. Among patients with type 2 diabetes (T2D), low medication adherence is linked wit...
Evolution of the Military Health System compounded drugs utilization and management [0.03%]
美军卫生系统的复合药物使用和管理的发展变迁分析
Teisha Robertson,Jessica Wong-Flores,Thomas Scott Raisor et al.
Teisha Robertson et al.
Over the past decade, the TRICARE pharmacy benefit has undergone significant changes, particularly in the management and utilization of compound drugs. Compound drugs are customized formulations that combine 2 or more pharmaceutical ingredi...
Social determinants of health and their impact on frontline treatment patterns among Medicare Advantage members with newly diagnosed multiple myeloma [0.03%]
影响医疗保险优势群体新诊断多发性骨髓瘤患者一线治疗模式的社会因素及其对健康的影响
Alexjandro Daviano,Yihua Xu,Brandon T Suehs et al.
Alexjandro Daviano et al.
Background: To improve health inequities, it is necessary to understand the impact of social determinants of health (SDoH), or social risk factors, including race and economic status, on multiple myeloma (MM) treatment pa...